Biocartis Group

Biocartis Group N.V.
Stock Exchange Euronext Brussels
EPS
EUR0.94
Market Cap
EUR603.29 M
Shares Outstanding
56.38 M
Public Float
40.78 M

Profile

Address
Generaal de Wittelaan 11 B3
Mechelen VL 2800
Belgium
Employees -
Website http://www.biocartis.com
Updated 07/08/2019
Biocartis Group NV is a commercial stage molecular diagnostics company, which engaegs in the provision of diagnostic solutions. It operates through MDx Idylla™ platform, an automated sample-to-result, real-time polymerase chain reaction system that offers molecular information from virtually any biological sample. The company was founded by Renaud Philippe, Nader Donzel, and Rudi Pauwels in July 2007 and is headquartered in Mechelen, Belgium.

Financials

View All
Created with Highcharts 5.0.14Biocartis Group N.V.Net Income. Fiscal year is January-December. All values EUR Thousands.27 44227 44229 18729 18739 79739 79749 77749 77741 96041 96048 15348 153201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Biocartis Group N.V.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.8 3338 3338 4788 47813 33413 33412 09812 09820 95720 95727 81127 81120132014201520162017201805k10k15k20k25k30k

Christian Reinaudo
Chairman
Herman Verrelst
Chief Executive Officer & Executive Director